Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction–associated ZO-1 protein organization

References

• Andras IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003; 74: 255–265
   PubMed Web of Science ®Google Scholar
• Avraham HK, Jiang S, Lee TH, Prakash O, Avraham S. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J Immunol 2004; 173: 6228–6233
   PubMed Web of Science ®Google Scholar
• Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol 1988; 25: 456–467
   PubMed Web of Science ®Google Scholar
• Brown MC, Cary LA, Jamieson JS, Cooper JA, Turner CE. Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness. Mol Biol Cell 2005; 16: 4316–4328
   Google Scholar
• Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 2008; 111: 2062–72
   PubMed Web of Science ®Google Scholar
• Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, Kim KS, Suzuki K, Jong AY. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 2003; 52: 961–970
   PubMed Web of Science ®Google Scholar
• Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999; 155: 1915–1927
   PubMed Web of Science ®Google Scholar
• Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006; 26: 1098–1106
   PubMed Web of Science ®Google Scholar
• Gautam R, Carter AC, Katz N, Butler IF, Barnes M, Hasegawa A, Ratterree M, Silvestri G, Marx PA, Hirsch VM, Pandrea I, Apetrei C. In vitro characterization of primary SIVsmm isolates belonging to different lineages. In vitro growth on rhesus macaque cells is not predictive for in vivo replication in rhesus macaques. Virology 2007; 362: 257–270
   Google Scholar
• Hirsch V, Adger-Johnson D, Campbell B, Goldstein S, Brown C, Elkins WR, Montefiori DC. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 1997; 71: 1608–1620
   Google Scholar
• Ilic D, Kovacic B, Johkura K, Schlaepfer DD, Tomasevic N, Han Q, Kim JB, Howerton K, Baumbusch C, Ogiwara N, Streblow DN, Nelson JA, Dazin P, Shino Y, Sasaki K, Damsky CH. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J Cell Sci 2004; 117: 177–187
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 2005; 64: 498–505
   PubMed Web of Science ®Google Scholar
• Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007; 13: 1173–1175
   PubMed Web of Science ®Google Scholar
• Kim TA, Avraham HK, Koh YH, Jiang S, Park IW, Avraham S. HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J Immunol 2003; 170: 2629–2637
   Web of Science ®Google Scholar
• Kusdra L, McGuire D, Pulliam L. Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS 2002; 16: 31–38
   PubMed Web of Science ®Google Scholar
• Lackner AA, Marx PA, Lerche NW, Gardner MB, Kluge JD, Spinner A, Kwang HS, Lowenstine LJ. Asymptomatic infection of the central nervous system by the macaque immunosuppressive type D retrovirus, SRV-1. J Gen Virol 1989; 70: 1641–1651
   Google Scholar
• Lackner AA, Smith MO, Munn RJ, Martfeld DJ, Gardner MB, Marx PA, Dandekar S. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 1991; 139: 609–621
   Google Scholar
• Leu TH, Su SL, Chuang YC, Ma MC. Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol 2003; 66: 2323–2331
   Google Scholar
• Linseman DA, Sorensen SD, Fisher SK. Attenuation of focal adhesion kinase signaling following depletion of agonist-sensitive pools of phosphatidylinositol 4,5-bisphosphate. J Neurochem 1999; 73: 1933–1944
   PubMedGoogle Scholar
• Lohmann C, Krischke M, Wegener J, Galla HJ. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res 2004; 995: 184–196
   PubMedGoogle Scholar
• Luabeya MK, Dallasta LM, Achim CL, Pauza CD, Hamilton RL. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathol Appl Neurobiol 2000; 26: 454–462
   PubMedGoogle Scholar
• MacLean AG, Belenchia GE, Bieniemy DN, Moroney-Rasmussen TA, Lackner AA. Simian immunodeficiency virus disrupts extended lengths of the blood–brain barrier. J Med Primatol 2005; 34: 237–242
   Google Scholar
• MacLean AG, Orandle MS, MacKey J, Williams KC, Alvarez X, Lackner AA. Characterization of an in vitro rhesus macaque blood-brain barrier. J Neuroimmunol 2002; 131: 98–103
   Google Scholar
• MacLean AG, Rasmussen TA, Bieniemy DN, Alvarez X, Lackner AA. SIV-induced activation of the blood-brain barrier requires cell-associated virus and is not restricted to endothelial cell activation. J Med Primatol 2004a; 33: 236–242
   PubMed Web of Science ®Google Scholar
• MacLean AG, Rasmussen TA, Bieniemy D, Lackner AA. Activation of the blood-brain barrier by SIV (simian immunodeficiency virus) requires cell-associated virus and is not restricted to endothelial cell activation. Biochem Soc Trans 2004b; 32: 750–752
   Google Scholar
• Mankowski JL, Queen SE, Kirstein LM, Spelman JP, Laterra J, Simpson IA, Adams RJ, Clements JE, Zink MC. Alterations in blood-brain barrier glucose transport in SIV-infected macaques. J NeuroVirol 1999; 5: 695–702
   Web of Science ®Google Scholar
• Mankowski JL, Spelman JP, Ressetar HG, Strandberg JD, Laterra J, Carter DL, Clements JE, Zink MC. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol 1994; 68: 8202–8208
   Google Scholar
• Orandle MS, Williams KC, MacLean AG, Westmoreland SV, Lackner AA. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J Virol 2001; 75: 4448–4452
   Google Scholar
• Orr AW, Murphy-Ullrich JE. Regulation of endothelial cell function BY FAK and PYK2. Front Biosci 2004; 9: 1254–1266
   PubMed Web of Science ®Google Scholar
• Orr AW, Pallero MA, Xiong WC, Murphy-Ullrich JE. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J Biol Chem 2004; 279: 48983–48992
   PubMedGoogle Scholar
• Persidsky Y, Gendelman HE. Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia. J Leukoc Biol 1997; 62: 100–106
   Google Scholar
• Persidsky Y, Nottet HS, Sasseville VG, Epstein LG, Gendelman HE. The development of animal model systems for HIV-1 encephalitis and its associated dementia. J NeuroVirol 1995; 1: 229–243
   Web of Science ®Google Scholar
• Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158: 3499–3510
   PubMed Web of Science ®Google Scholar
• Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, Takikawa O, Munn DH, Gendelman HE, Persidsky Y. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 2005; 106: 2382–2390
   PubMed Web of Science ®Google Scholar
• Ramesh G, Philipp MT. Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins. Neurosci Lett 2005; 384: 112–116
   Google Scholar
• Retta SF, Barry ST, Critchley DR, Defilippi P, Silengo L, Tarone G. Focal adhesion and stress fiber formation is regulated by tyrosine phosphatase activity. Exp Cell Res 1996; 229: 307–317
   PubMed Web of Science ®Google Scholar
• Ruest PJ, Roy S, Shi E, Mernaugh RL, Hanks SK. Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site. Cell Growth Differ 2000; 11: 41–48
   PubMedGoogle Scholar
• Sasseville VG, Newman W, Brodie SJ, Hesterberg P, Pauley D, Ringler DJ. Monocyte adhesion to endothelium in simian immunodeficiency virus- induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am J Pathol 1994; 144: 27–40
   PubMedGoogle Scholar
• Sasseville VG, Newman WA, Lackner AA, Smith MO, Lausen NC, Beall D, Ringler DJ. Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol 1992; 141: 1021–1030
   PubMed Web of Science ®Google Scholar
• Sawada Y, Sheetz MP. Force transduction by Triton cytoskeletons. J Cell Biol 2002; 156: 609–615
   Google Scholar
• Selmaj K. Pathophysiology of the blood-brain barrier. Springer Semin Immunopathol 1996; 18: 57–73
   Google Scholar
• Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 2005; 19: 45–52
   PubMed Web of Science ®Google Scholar
• Staddon JM, Herrenknecht K, Smales C, Rubin LL. Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci 1995; 108(Pt 2)609–619
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. Potential role of MCP-1 in endothelial cell tight junction'opening': signaling via Rho and Rho kinase. J Cell Sci 2003; 116: 4615–4628
   PubMed Web of Science ®Google Scholar
• Stins MF, Pearce D, Di Cello F, Erdreich-Epstein A, Pardo CA, Sik Kim K. Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors. Lab Invest 2003; 83: 1787–1798
   PubMed Web of Science ®Google Scholar
• Usatyuk PV, Natarajan V. Regulation of reactive oxygen species-induced endothelial cell-cell and cell-matrix contacts by focal adhesion kinase and adherens junction proteins. Am J Physiol Lung Cell Mol Physiol 2005; 289: 999–1010
   Google Scholar
• Wachtel M, Frei K, Ehler E, Fontana A, Winterhalter K, Gloor SM. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci 1999; 112(Pt 23)4347–56
   PubMed Web of Science ®Google Scholar
• Westmoreland SV, Halpern E, Lackner AA. Simian immunodeficiency virus encephalitis in rhesus macaques is associated with rapid disease progression. J NeuroVirol 1998; 4: 260–268
   Web of Science ®Google Scholar
• Yuan Y, Meng FY, Huang Q, Hawker J, Wu HM. Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function. Am J Physiol 1998; 275: H84–H93
   PubMed Web of Science ®Google Scholar